You have 9 free searches left this month | for more free features.

City

Atlanta (1)

Cairo (1)

Gurgaon (1)

Minneapolis (1)

New York (1)

Split (1)

Spokane (1)

Condition

Type 2 Diabetes (2)

Diabetes Mellitus (1)

Diabetes Mellitus, Type 2 (1)

Type 1 Diabetes Mellitus With Hypoglycemia (1)

type1diabetes (1)

Overall Status

Completed (3)

Recruiting (1)

Terminated (1)

Sign in for free

Phase

phase 4 (3)

n/a (2)

Sponsor

Ain Shams University (1)

Emory University (1)

Hennepin Healthcare Research Institute (1)

Medanta, The Medicity, India (1)

University of Split, School of Medicine (1)

Intervention

degludec (5)

glargine (2)

glargine u300 (2)

aspart (1)

nph insulin (1)

standard long-acting (1)

Study Documents

Intervention Type

drug (5)

Funder Type

Other (5)

Study Type

Interventional (5)

degludec

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Type 2 Diabetes Trial in Gurgaon (Degludec, Glargine U300)

Completed

Type 2 Diabetes

Degludec
Glargine U300

Gurgaon, Haryana, India

Division Of Endocrinology and Diabetes , Medanta The Medicity Ho

Mar 3, 2022

Type 2 Diabetes Trial in Atlanta, New York, Spokane (Degludec, Glargine, Aspart)

Completed

Type 2 Diabetes

Degludec
+2 more

Atlanta, Georgia
+3 more

Mar 25, 2022

Diabetes Trial in Minneapolis (Degludec, Standard long-acting)

Terminated

Diabetes Mellitus

Degludec
Standard long-acting

Minneapolis, Minnesota

Hennepin County Medical Center

May 13, 2021

Diabetes, Type 2 Trial in Split (Degludec, Glargine U300)

Completed

Diabetes Mellitus, Type 2

Degludec
Glargine U300

Split, Croatia

Klinički bolnički Centar Split

Dec 29, 2020

Type 1 Diabetes With Hypoglycemia, type1diabetes Trial in Cairo (Degludec, Glargine, NPH insulin)

Recruiting

Type 1 Diabetes Mellitus With Hypoglycemia
type1diabetes

Degludec
+2 more

Cairo, Egypt

Ain Shams University

Feb 12, 2021